Cardiac Surgical Pathology

3 downloads 0 Views 4MB Size Report
Can be local (compensatory hypertrophy in MI) or global ... Myocardial Stunning: Reversible post-ischemic ... Papillary muscle rupture tends to occur later.
CARDIAC SURGICAL PATHOLOGY

GENERAL CONSIDERATIOS 

Myocardial Hypertrophy  Compensatory

response of the myocardium to increased work.

 Leads

to overall increase in the size and mass of the heart

 The

vasculature doesn’t proliferate, leaving hypertrophied myocardium vulnerable to ischemia

MYOCARDIAL HYPERTROPHY 

The pattern of hypertrophy reflects the nature of the stimulus. 

Concentric Hypertrophy = Pressure overloaded ventricles ( increased mass and thickness without appreciable dilation)



Dilation + Hypertrophy = Volume overloaded ventricles (increased mass, thickness, and chamber radius)



Can be local (compensatory hypertrophy in MI) or global (Valvular heart diseases or dilated CM)

ATHEROSCLEROSIS 

Chronic progressive, multifocal disease of vessel wall intima.



The plaque is formed by a process of intimal thickening and lipid accumulation.



Mainly affects large and medium sized muscular arteries



Large epicardial vessels: proximal LAD, Cx, RCA.

THEORY OF ATHEROGENESIS 

1st catalyst: Endothelial cell injury Hyperchloestremia  Chemicals in cigarettes  Viruses  Hypertension  Hyperglycemia 



Functional and phenotypic changes occur in the endothelium, termed endothelial dysfunction.

ENDOTHELIAL DYSFUNCTION 

Manifestations:  Vasoconstriction 

due  production of NO

permeability to lipoproteins

 Expression  Expression

of tissue factor leading to thrombosis

of adhesion molecules leading to adherence of platelets and inflammatory cells.

ATHEROGENESIS

ATHEROGENESIS 

Events leading to the formation of a mature plaque Monocyte adherence to endothelial cells and migration to subendothelial space  macrophages  Smooth muscle cell migration from media to intima and proliferation + secretion of ECM  Lipid accumulation, both extracellular and intacellular (foam cells) in both macrophages and SM cells.  Lipid oxidation in the vessel walls  Persistent chronic inflammation  Cell death and release of intracellular lipids 

STAGES OF ATHEROSCLEROSIS

NATURAL HISTORY OF ATHEROSCLEROSIS

ISCHEMIC MYOCARDIAL INJURY



Cardiac ischemia occurs when perfusion is inadequate to meet the metabolic demands of the myocardium



The severity and duration of ischemia determine the consequent damage that occurs.

Area at risk: area perfused by obstructed coronary artery. Infarcts extend from the subendocardium towards the epicardium, producing a transmural infarct.

SOME TERMS ASSOCIATED WITH ISCHEMIA 

Myocardial Stunning: Reversible post-ischemic myocardial dysfunction.



May occur following CPB, PCI.

Hibernating Myocardium: Viable regions of myocardium with chronically impaired function in the setting of chronically reduced coronary blood flow  Myocardial hibernation is characterized by: 

 Persistent

wall motion abnormality  Low myocardial blood flow  Evidence of viability of at least some of the affected areas.

HIBERNATING MYOCARDIUM 

Contractile function of hibernating myocardium can improve if blood flow returns toward normal or if oxygen demand is reduced (with CABG or PCI)

CAUSES OF CORONARY ARTERY OBSTRUCTION 

Fixed Atherosclerotic obstructions (MC)



Autoimmune diseases (SLE, RA)



Vasculitis (Buerger’s disease, Kawasaki)



Coronary artery Spasm (prinzmetal’s)



Dissection



Embolism



Fibromuscular dysplasia

MYOCARDIAL INFARCTION 

Coronary plaque rupture with superimposed thrombosis typically lead to a transmural (fullthickness) Q-wave infarct.



Subendocardial infarcts are commonly associated with diffuse stenosing coronary atherosclerosis without acute plaque rupture or superimposed thrombosis in the setting of episodic hypotension, global ischemia, or hypoxemia

FULL THICKNESS VS SUBENDOCARDIAL

MORTALITY AND MORBIDITY 

The mortality of AMI has declined from 30% in the 1960s to 10% today.



50% of deaths occur in the 1st hour before the patient reaches the hospital.



Poor prognostic factors: advanced age, female gender, previous MI and DM.



Factors determining long-term prognosis: LV function and extent of obstructing lesions

COMPLICATIONS OF MI Ventricular dysfunction (Myocardial Stunning)  Cardiogenic shock (>40% of LV)  Arrhythmias (AF, VF, Tachyarrythmias)  Myocardial rupture  Papillary muscle dysfunction  Ventricular aneurysm  Pericarditis  Systemic arterial embolism (mural thrombi) 

COMPLICATIONS OF MI 

Mechanical complications tend to occur more in patients with anterior infarcts.



Postero-inferior infarcts tend to have associated conduction abnormalities.

RUPTURE SYNDROMES AND OTHER COMLICATIONS OF MI

CARDIAC RUPTURE SYNDROMES 

Rupture of the ventricular free wall (most common).



Rupture of the ventricular septum (less common).



Papillary muscle rupture (least common), resulting in the acute onset of severe MR.

CARDIAC RUPTURE Cardiac rupture is the cause of death in 8- 10% of acute transmural myocardial infarcts.  Ruptures tend to occur relatively early following infarction(1st ten days)  25% present within 24 hours of MI.  Although the lateral wall is the least common site for left ventricular infarction, it is the most common site for postinfarction free-wall rupture.  Rapidly fatal, very rarely amendable by surgery 

ACUTE VSD 

Complicate 1 to 2% of infarcts.



Without surgery, the prognosis following infarctrelated septal rupture is poor

PAPILLARY MUSCLE DYSFUNCTION 

Posteromedial papillary muscle is more susceptible to widespread necrosis and is more commonly (85%) the site of rupture.



Papillary muscle rupture tends to occur later than other rupture syndromes (as late as 1 month after MI).

EFFECTS OF REPERFUSION 

Reperfusion occurring before irreversible damage (20 minutes) can limit infarct size or prevent it altogether.



Later reperfusion (6-12hrs) can salvage myocardium located at the leading edge of the wavefront.

CONSEQUENCES OF REPERFUSION

ATHEROSCLEROSIS IN GRAFTS The patency of saphenous vein grafts is reported as 60% at 10 years.  Between 1 month and 1 year, graft stenosis is usually caused by intimal hyperplasia with excessive smooth muscle proliferation and extracellular matrix production.  Atherosclerosis becomes the more dominant mechanism in graft occlusion beyond 1 to 3 years after CABG. 

CAUSES OF ACCELERATED ATHEROSCLEROSIS IN VENOUS GRAFTS Loss of vaso vasorum  Nerve damage  Acutely increased pressures  Medial necrosis  Endothelial Damage (during surgical manipulation) 

SAPHENOUS VEIN GRAFT ATHEROSCLEROSIS



Atheroembolization is a major risk, often with catastrophic results; due to weakness of the fibrous cap.

LIMA



The IMA has a >90% patency rate at 10 years.



Causes:  Minimal

surgical manipulation  maintains its nutrient blood supply  accustomed to arterial pressures  needs no proximal anastomosis,  minimal pre-existing ather- osclerosis in most cases.

VALVULAR HEART DISEASE Normal valve function requires structural integrity and coordinated interactions among multiple anatomic components.  For the AV valves, these elements include 

 leaflets,  commissures  annulus  chordae

tendineae  papillary muscles



For the semilunar valves (aortic and pulmonary), the key structures are the   

Cusps Commissures Supporting structures in the aortic and pulmonary roots

PATHOLOGIC DEFINITIONS 

Valvular stenosis: defined as inhibition of forward flow secondary to obstruction caused by failure of a valve to open completely.



Valvular insufficiency: defined as reverse flow caused by failure of a valve to close completely.



Both stenosis and insufficiency can coexist in a single valve, usually with one process predominating

AORTIC STENOSIS Prevalence: 2% of the population  Etiology:  Congenitally abnormal aortic valve (unicuspid or bicuspid) with superimposed calcification. (38%)  Degenerative Calcification of trileaflet valve. (33%)  Rheumatic heart disease. (24%)  Rare causes: Fabry’s disease, SLE, alkaptonuria and Paget’s disease. 

AORTIC STENOSIS

PATHOPHYSIOLOGY OF AS

Gradual aortic outflow obstruction due to stenosis

Increased pressure gradient across aortic valve

Concentric LVH to maintain CO

Exhaustion of compensatory mechanisms

Onset of symptoms (angina, syncope) and heart failure

BICUSPID AORTIC VALVE Prevalence: 1% of the population  Bicuspid aortic valve (BAV) is the most frequent congenital cardiovascular malformation in humans.  Male : Female ratio of 3-4:1.  Two cusps are typically of unequal size,  Bicuspid valves are predisposed to accelerated calcification, with about 85% becoming stenotic. 

Aortic jet velocity, m/sec

Mean gradient, mmHg

Valve area, cm2

Normal

≤1.5

40